[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB889262A - Quinoline compounds - Google Patents

Quinoline compounds

Info

Publication number
GB889262A
GB889262A GB23178/60A GB2317860A GB889262A GB 889262 A GB889262 A GB 889262A GB 23178/60 A GB23178/60 A GB 23178/60A GB 2317860 A GB2317860 A GB 2317860A GB 889262 A GB889262 A GB 889262A
Authority
GB
United Kingdom
Prior art keywords
group
groups
substituted
unsubstituted
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB23178/60A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba AG filed Critical Ciba AG
Publication of GB889262A publication Critical patent/GB889262A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises quinolines which contain in the 3-position an unsubstituted or substituted guanidino group and which are unsubstituted or C-substituted by a lower alkyl or a lower alkoxy or an alkylene dioxy group, their physiologically tolerable acid addition salts, acyl derivatives and quaternary ammonium salts, pharmaceutical preparations containing these compounds (see Group VI)., and the preparation of the compounds by reacting a 3-aminoquinoline with an S-alkylisothiourea or a cyanamide and, if desired, in a resulting quinolyl-(3)-guanidine whose imino or amino groups are unsubstituted, substituting the latter by hydrocarbon radicals or acyl radicals and/or converting the resulting free compound into a salt or a salt into the free compound. Substituents of the guanido group include alkyl, alkylene (in which instance when the alkylene group is ethylene the guanido group is a 4,5-dihydroimidazoyl-(2)-amino group) and acyl groups. Acyl groups are derived from acids such as lower alkoxy carbonic, carbamic, lower alkanoic, lower alkenoic, lower alkynoic, b -cyclopentylpropionic, monohaloacetic, trifluoracetic, methoxy acetic, dimethylaminoacetic, b -dimethylaminopropionic, b -piperidinopropionic, benzoic, methoxybenzoic, 3,4,5-trimethoxybenzoic, 4-O-ethoxysyringic, 3,4-dichlorobenzoic, 3-nitrobenzoic, 3 dimethylaminobenzoic, nicotinic, isonicotinic, 2-furancarboxylic, 2-thiophenecarboxylic, phenyl- or diphenyl-acetic, b -phenylpropionic, p-methoxyphenylacetic, cinnamic, p-chlorocinnamic, 3,4,5-trimethoxycinnamic, pyridyl-(2)-acetic and thienyl-(2)-acetic acids. Lower alkyl and alkoxy groups contain 1 and 7 carbon atoms.ALSO:Pharmaceutical compositions having anti-hypertensive activity comprise quinolines substituted in the 3 position by guanidino groups and optionally C-substituted by lower alkyl or lower alkoxy groups (i.e. containing 1-7 carbon atoms), their acyl derivatives, acid addition or quaternary ammonium salts and a pharmaceutical carrier. The guanidino groups may be unsubstituted or substituted by alkyl or alkylene groups (in which latter instance the guanidino group is converted into a heterocyclic ring e.g. a - 4 : 5 - dihydro - imidazolyl - (2) - amino group with ethylene). Acyl derivatives are derived from aliphatic, monocyclic aromatic, heterocyclic araliphatic or heterocyclic-aliphatic carboxylic acids, salts from therapeutically useful organic and inorganic acids and quaternary ammonium salts from reactive esters of alkanols or aralkanols. The compositions are in a form suitable for enteral or parenteral administration such as tablets, dragees, capsules, solutions, suspensions or emulsions and may contain other therapeutically useful substances.
GB23178/60A 1959-07-03 1960-07-01 Quinoline compounds Expired GB889262A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH889262X 1959-07-03

Publications (1)

Publication Number Publication Date
GB889262A true GB889262A (en) 1962-02-14

Family

ID=4545590

Family Applications (1)

Application Number Title Priority Date Filing Date
GB23178/60A Expired GB889262A (en) 1959-07-03 1960-07-01 Quinoline compounds

Country Status (1)

Country Link
GB (1) GB889262A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2407930A1 (en) * 1977-11-07 1979-06-01 Rech Applications Therap NEW 4-QUINOLYL-GUANIDINES, USEFUL IN PARTICULAR AS ANTI-INFLAMMATORY, AND THEIR PREPARATION PROCESS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2407930A1 (en) * 1977-11-07 1979-06-01 Rech Applications Therap NEW 4-QUINOLYL-GUANIDINES, USEFUL IN PARTICULAR AS ANTI-INFLAMMATORY, AND THEIR PREPARATION PROCESS

Similar Documents

Publication Publication Date Title
FI91525C (en) Process for the preparation of therapeutically active pyridine-2,4- and -2,5-dicarboxylic acid amides
US5116848A (en) N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
KR102163608B1 (en) Antimicrobial agents
GB1416872A (en) 4-aminoquinoline derivatives
GB890602A (en) New pyridine compounds and process for their manufacture
GB889262A (en) Quinoline compounds
GB1531963A (en) Pyrido(1,2alpha)pyrimidine derivatives
GB1427139A (en) Penicillins
IL33846A (en) Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them
IE33862B1 (en) Thiepin and oxepin derivatives,processes for their production and medicaments containing same
US20030171304A1 (en) Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
GB919073A (en) Benzylamine derivatives
Katritzky et al. 248. N-oxides and related compounds. Part X. The hydrogenation of some pyridine 1-oxides
GB1259814A (en) Benzimidazoles
NO752078L (en)
GB862721A (en) Dialkylaminoethyl derivatives of salicylamides
GB1322987A (en) On,n-diacylhydroxylamine derivatives and preparation
GB1231250A (en)
US3072650A (en) Amides of 2-(aminomethyl)-oxacycloalkanes
GB2290786A (en) Quinoline derivatives
GB1353508A (en) Aminoisoquinolines
GB1161062A (en) Active Sulphonamides
US3330837A (en) Substituted hydrazine derivatives and process for the manufacture thereof
US3056791A (en) Isoquinoline derivatives
GB1014883A (en) Therapeutically active derivatives of 7-amino-cephalosporanic acid and process for the manufacture of 7-amino-cephalosporanic acid